Clinical trial
Peripheral Microvascular Resistance as a Predictor for Limb Salvage in Post-Intervention Critical Limb Ischemia Patients
NCT06014242 is registered in ClinicalTrials.gov with Hackensack Meridian Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Peripheral Microvascular Resistance as a Predictor for Limb Salvage in Post-Intervention Critical Limb Ischemia Patients
- Lead sponsor
- Hackensack Meridian Health
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- September 15, 2025
- Completion date
- September 15, 2026
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.